Citations 1
Randomized comparison of ibrutinib versus ofatumumab in relapsed or refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the phase III RESONATE trial.
Byrd, John C. , Brown, Jennifer R. , Reddy, Nishitha , Jäger, Ulrich, Devereux, Steve, Furman, Richard R. , Cymbalista, Florence, Fardis, Maria, McGreivy, Jesse, Clow, Fong, James, Danelle F. , Hillmen, Peter, O’Brien, Susan , Barrientos, Jacqueline C. , Kay, Neil E. , Coutré, Steven , Tam, Constantine S. , Mulligan, Stephen P. , Devereux, Steve, Barr, Paul M. , Kipps, Thomas J.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: LBA7008-LBA7008
